The Valley Desk

NCT02682407 · Interventional trial

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Overall registry status Terminated

Phase 2

Conditions C3G, IgAN, LN, MN

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov